A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine

by | Jun 12, 2025 | Clinical Trials | 0 comments

​ Conditions: Episodic Migraine

Interventions: Drug: Xeomin; Drug: Placebo

Sponsors: Merz Therapeutics GmbH

Not yet recruiting Conditions: Episodic Migraine
Interventions: Drug: Xeomin; Drug: Placebo
Sponsors: Merz Therapeutics GmbH
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *